More trials are cut short, but not the debate over their trajectory.
Madhumita
M
Venkataramanan
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000225:Adenine / Q000031:analogs & derivatives / Q000627:therapeutic use; D002986:Clinical Trials as Topic / Q000941:ethics* / Q000639:trends*; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000068679:Emtricitabine; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D009525:Niacin / Q000627:therapeutic use; D063065:Organophosphonates / Q000627:therapeutic use; D000068698:Tenofovir
D063065:Organophosphonates; D003841:Deoxycytidine; D009525:Niacin; D000068698:Tenofovir; D000068679:Emtricitabine; D000225:Adenine